BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21741230)

  • 61. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.
    Chi KH; Chen CH; Chan WK; Chow KC; Chen SY; Yen SH; Chao JY; Chang CY; Chen KY
    J Clin Oncol; 1995 Oct; 13(10):2620-8. PubMed ID: 7595716
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
    Harada K; Ferdous T; Horinaga D; Uchida K; Mano T; Mishima K; Park S; Hanazawa H; Takahashi S; Okita A; Fukunaga M; Maruta J; Kami N; Shibuya K; Ueyama Y
    Support Care Cancer; 2016 Feb; 24(2):953-959. PubMed ID: 26248650
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation.
    Antunes HS; Schluckebier LF; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Rampini MP; Ferreira EM; Dias FL; Teich V; Teich N; Ferreira CG
    Oral Oncol; 2016 Jan; 52():85-90. PubMed ID: 26559740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy and/or molecular targeted therapy].
    Zhang XX; Ma L; Wang JL; Wu WM; Feng LC; Huang DL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):505-8. PubMed ID: 21924104
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of a daily dose of Lactobacillus brevis CD2 lozenges in high caries risk schoolchildren.
    Campus G; Cocco F; Carta G; Cagetti MG; Simark-Mattson C; Strohmenger L; Lingström P
    Clin Oral Investig; 2014; 18(2):555-61. PubMed ID: 23644602
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis.
    Daugėlaitė G; Užkuraitytė K; Jagelavičienė E; Filipauskas A
    Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30678228
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
    Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multi-Sensor Approach for the Monitoring of Halitosis Treatment via Lactobacillus brevis (CD2)-Containing Lozenges--A Randomized, Double-Blind Placebo-Controlled Clinical Trial.
    Marchetti E; Tecco S; Santonico M; Vernile C; Ciciarelli D; Tarantino E; Marzo G; Pennazza G
    Sensors (Basel); 2015 Aug; 15(8):19583-96. PubMed ID: 26266414
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of the plantago major L. syrup on radiation induced oral mucositis in head and neck cancer patients: A randomized, double blind, placebo-controlled clinical trial.
    Soltani GM; Hemati S; Sarvizadeh M; Kamalinejad M; Tafazoli V; Latifi SA
    Complement Ther Med; 2020 Jun; 51():102397. PubMed ID: 32507421
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
    Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Acta Otolaryngol; 2015 Aug; 135(8):853-8. PubMed ID: 25814008
    [TBL] [Abstract][Full Text] [Related]  

  • 72. SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study.
    Pawar D; Neve RS; Kalgane S; Riva A; Bombardelli E; Ronchi M; Petrangolini G; Morazzoni P
    Support Care Cancer; 2013 Mar; 21(3):827-34. PubMed ID: 22945882
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis.
    Hawley P; Hovan A; McGahan CE; Saunders D
    Support Care Cancer; 2014 Mar; 22(3):751-61. PubMed ID: 24221577
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of individual in vivo repair of DNA double-strand breaks on oral mucositis in adjuvant radiotherapy of head-and-neck cancer.
    Fleckenstein J; Kühne M; Seegmüller K; Derschang S; Melchior P; Gräber S; Fricke A; Rübe CE; Rübe C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1465-72. PubMed ID: 20947264
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]).
    Leenstra JL; Miller RC; Qin R; Martenson JA; Dornfeld KJ; Bearden JD; Puri DR; Stella PJ; Mazurczak MA; Klish MD; Novotny PJ; Foote RL; Loprinzi CL
    J Clin Oncol; 2014 May; 32(15):1571-7. PubMed ID: 24733799
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.
    Lalla RV; Choquette LE; Curley KF; Dowsett RJ; Feinn RS; Hegde UP; Pilbeam CC; Salner AL; Sonis ST; Peterson DE
    Oral Oncol; 2014 Nov; 50(11):1098-103. PubMed ID: 25151488
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis.
    Verdi CJ; Garewal HS; Koenig LM; Vaughn B; Burkhead T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jul; 80(1):36-42. PubMed ID: 7552860
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.
    Hong JP; Lee SW; Song SY; Ahn SD; Shin SS; Choi EK; Kim JH
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):636-41. PubMed ID: 19456848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.